Heart pump data study aims to sharpen shock monitoring

NCT ID NCT06308055

Recruiting now Knowledge-focused Sponsor: Abiomed Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study gathers detailed, real-time information from the Impella heart pump and standard hospital monitors in 125 people with cardiogenic shock. The goal is to better understand how the pump and the body's vital signs work together. No new treatment is being tested; instead, researchers are collecting data to improve future care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIOGENIC SHOCK are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cardiogenic shock Shock, Cardiogenic

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CARDIOGENIC SHOCK

Contacts and locations

Locations

IRCCS Ospedale San Raffaele
NOT_YET_RECRUITING

Milan, MI, 20132, Italy
UKSH Campus Kiel
NOT_YET_RECRUITING

Kiel, Schleswig-Holstein, 24105, Germany
Uniklinik RWTH Aachen
ACTIVE_NOT_RECRUITING

Aachen, North Rhine-Westphalia, 52074, Germany
Universitätsspital Basel
RECRUITING

Basel, Switzerland

More trials for these conditions

Other studies related to the condition(s) this trial covers.